| Name: | Bexagliflozin |
|---|---|
| CAS:: | 1118567-05-7 |
| Molecular Formula: | C24H29ClO7 |
| Standard: | In-house |
| Documentation: | CDMF |
| Development stage: | Commercialization |
Bexagliflozin
Bexagliflozin, sold under the brand name Brenzavvy, is an antidiabetic medication used to improve glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that is taken by mouth.